NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/15/2025
Back to search
Official data from USPTO
MCE MEDCHEM EXPRESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
02/04/2025
Classification
Registered
Trademark type
Combined
Nice classes
1, 42
Filing date
06/12/2014
Registration date
01/27/2015
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/15/2025
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
03/17/2009
First use in commerce
03/17/2009
Drawing code
3
Owner type
99
Owner location
SHANGHAI, CN
Examiner
TRUSILO, KELLY
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD.
SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD.
Representatives
Xiaofei Xue
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparation for use in cell cultures other than for medical or veterinary use; Biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Cells for scientificlaboratory or medical research; Chemical preparations for scientific purposes; Chemical test kits for biological and pharmaceutical study for laboratory or research use; Diagnostic reagents for clinical or medical laboratory use; Laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
Class 42
Bacteriological research; Biological research; Chemical analysis; Chemical research; Chemicalbiochemicalbiological and bacteriological research and analysis; Cosmetics research; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research on the subject of pharmaceuticals; Scientific research
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/15/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/15/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/15/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
09/26/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/27/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/11/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/11/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/09/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/09/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/31/2020
E815
TEAS SECTION 8 & 15 RECEIVED
06/15/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/27/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/11/2014
PUBO
PUBLISHED FOR OPPOSITION
11/11/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/22/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/07/2014
ALIE
ASSIGNED TO LIE
10/07/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/22/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
09/22/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/22/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
09/22/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/22/2014
DOCK
ASSIGNED TO EXAMINER
09/19/2014
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/24/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/23/2014
NWAP
NEW APPLICATION ENTERED
06/16/2014
Continuous trademark protection
Get notified about every new filing that threatens MCE MEDCHEM EXPRESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.